Rejected at 10:38 p.m. Jun, 03, 2024 ] by Cameron
Author: zarathustra
Related Note: 1461794791535
Rationale for change

Since oxidative burst primarily occurs in neutrophils and monocytes (https://www.amboss.com/us/snippet/Respiratory_Burst) and not in macrophages (https://www.amboss.com/us/knowledge/innate-immune-system#), I find this misleading

Rejection reason

Macrophages are differentiated monocytes

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::AnKing_Image::!Subjects::Immunology_&_Pathology::Chronic_Granulomatous_Disease #AK_Other::Only_Step_1 #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::07_Respiratory_burst::*Chronic_Granulomatous_Disease #AK_Other::AnKing_Image::AhmedA::Chronic_Granulomatous_Disease #AK_Step1_v12::#OME::03_Immune::01_Immunology::16_Immunosuppression #AK_Step1_v12::#AMBOSS::QYauKQ #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::04_Immunology::01_Interferons #AK_Step1_v12::#OME::03_Immune::01_Immunology::15_Immunodeficiency #AK_Step1_v12::#B&B::14_Infectious_Disease::01_Basics_of_Microbiology::07_Bacterial_Identification::Extra #AK_Step1_v12::#Bootcamp::Biochemistry::07_Oxidative_Stress::04_Respiratory_(Oxidative)_Burst:_Clinical_Implications #AK_Step1_v12::^Systems::GI::pharm #AK_Other::AnKing_Image::Aiman::Respiratory_Burst #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::02_Recombinant_cytokines_and_clinical_uses #AK_Step1_v12::#NBME::21 #AK_Step1_v12::#Physeo::08_Immunology::02_Immunodeficiencies::14_Chronic_Granulomatous_Disease_(CGD) #AK_Other::AnKing_Image::!Subjects::Immunology_&_Pathology::Respiratory_Burst #AK_Step1_v12::#Pixorize::02_Immunology::06_Immunodeficiencies::08_Chronic_Granulomatous_Disease_(CGD) #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#OME::PreClinical::03_Immune::01_Immunology::15_Immunodeficiency #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::09_Interferons_Alpha,_Beta,_&_Gamma #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::16_Immunodeficiencies::04_Phagocyte_dysfunction::*Chronic_Granulomatous_Disease #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::02_Recombinant_cytokines_and_clinical_uses::02_Immunotherapy::*IFN-y